Hepatitis A virus in the Middle East and North Africa region: A new challenge

Journal of Viral Hepatitis

Volumn 21, Issue 9, 2014, Pages 605-615

  Melhem, N M ^a   Talhouk, R ^a   Rachidi, H ^a   Ramia, S ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

hepatitis A vaccine; hepatitis A virus; Middle East and North Africa; risk factors; seroprevalence

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS A ANTIBODY;

DESALINATION; DRUG SURVEILLANCE PROGRAM; ENVIRONMENTAL SANITATION; GROUPS BY AGE; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; IMMUNIZATION; INFECTION RISK; MIDDLE EAST; MORBIDITY; NORTH AFRICA; PRIORITY JOURNAL; REVIEW; SEROPREVALENCE; WASTE WATER MANAGEMENT; WATER SUPPLY; AFRICA; BLOOD;

AFRICA, NORTHERN; HEPATITIS A; HEPATITIS A ANTIBODIES; HUMANS; MIDDLE EAST; SEROEPIDEMIOLOGIC STUDIES;

EID: 84905436093     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12282     Document Type: Review

References (90)

1. Advisory Committee on Immunization P, Fiore AE, Wasley A, Bell BP,. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55 (RR-7): 1-23.
2. Jacobsen KH, Wiersma ST,. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine 2010; 28 (41): 6653-6657.
3. Jacobsen KH, Koopman JS,. The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns. Int J Epidemiol 2005; 34 (3): 600-609.
4. Jacobsen KH, Koopman JS,. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect 2004; 132 (6): 1005-1022.
5. Luyten J, Beutels P,. Costing infectious disease outbreaks for economic evaluation: a review for hepatitis A. Pharmacoeconomics 2009; 27 (5): 379-389.
6. Hendrickx G, Van Herck K, Vorsters A, et al,. Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology. J Viral Hepat 2008; 15 (Suppl. 2): 1-15.
7. Ceyhan M, Yildirim I, Kurt N, et al,. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations. J Viral Hepat 2008; 15 (Suppl. 2): 69-72.
8. Kaya AD, Ozturk CE, Yavuz T, et al,. Changing patterns of hepatitis A and E sero-prevalences in children after the 1999 earthquakes in Duzce, Turkey. J Paediatr Child Health 2008; 44 (4): 205-207.
9. Kaya D, Guler E, Ekerbicer HC, et al,. Hepatitis A seroprevalence and its relationship with environmental factors in children of different age groups in Kahramanmaras, Eastern Mediterranean region of Turkey. J Viral Hepat 2007; 14 (12): 830-834.
10. Soysal A, Gokce I, Pehlivan T, et al,. Interchangeability of a hepatitis A vaccine second dose: Avaxim 80 following a first dose of Vaqta 25 or Havrix 720 in children in Turkey. Eur J Pediatr 2007; 166 (6): 533-539.
11. Egemen A, Yilmaz O, Akil I, et al,. Evaluation of association between hepatitis A and Helicobacter pylori infections and routes of transmission. Turk J Pediatr 2006; 48 (2): 135-139.
12. Oncu S, Oncu S, Sakarya S,. Hepatitis A and B seropositivity among medical students. Health Policy 2005; 74 (1): 39-45.
13. Sencan I, Sahin I, Kaya D, et al,. Assessment of HAV and HEV seroprevalence in children living in post-earthquake camps from Duzce, Turkey. Eur J Epidemiol 2004; 19 (5): 461-465.
14. Tosun S, Ertan P, Kasirga E, et al,. Changes in seroprevalence of hepatitis A in children and adolescents in Manisa, Turkey. Pediatr Int 2004; 46 (6): 669-672.
15. Erdogan MS, Otkun M, Tatman-Otkun M, et al,. The epidemiology of hepatitis a virus infection in children, in Edirne, Turkey. Eur J Epidemiol 2004; 19 (3): 267-273.
16. Halicioglu O, Akman SA, Tatar B, et al,. Hepatitis A seroprevalence in children and adolescents aged 1-18 years among a low socioeconomic population in Izmir, Turkey. Travel Med Infect Dis 2012; 10 (1): 43-47.
17. Ceran N, Yuksel Kocdogan F, Mert D, et al,. Hepatitis A seroprevalence in children and young adults in Istanbul, Turkey: seroprevalence change and associated factors. J Viral Hepat 2012; 19 (1): 72-76.
18. Ince OT, Yalcin SS, Yurdakok K, et al,. Hepatitis A seroprevalence among infants aged 12 months in Ankara. Turk J Pediatr 2011; 53 (1): 114-116.
19. Deveci U, Ustun C, Hamanca O,. Seroprevalence of hepatitis A virusamong children aged 1-16 years in Eastern Anatolia, Turkey. Afr J Microbiol Res 2011; 5 (32): 5969-5971.
20. Ataei B, Javadi AA, Nokhodian Z, et al,. HAV in Isfahan province: a population-based study. Trop Gastroenterol 2008; 29 (3): 160-162.
21. Mohebbi SR, Rostami Nejad M, Tahaei SM, et al,. Seroepidemiology of hepatitis A and E virus infections in Tehran, Iran: a population based study. Trans R Soc Trop Med Hyg 2012; 106 (9): 528-531.
22. Merat S, Rezvan H, Nouraie M, et al,. Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study. Arch Iran Med 2010; 13 (2): 99-104.
23. Sofian M, Aghakhani A, Farazi AA, et al,. Seroepidemiology of hepatitis A virus in children of different age groups in Tehran, Iran: implications for health policy. Travel Med Infect Dis 2010; 8 (3): 176-179.
24. Alian S, Ajami A, Ghasemian R, et al,. Age-specific seroprevalence of hepatitis A in Sari, northern Islamic Republic of Iran. East Mediterr Health J 2011; 17 (10): 754-758.
25. Saffar MJ, Abedian O, Ajami A, et al,. Age-specific seroprevalence of anti-hepatitis a antibody among 1-30 years old population of Savadkuh, Mazandaran, Iran with literature review. Hepat Mon 2012; 12 (5): 326-332.
26. Taghavi Ardakani A, Soltani B, Sehat M, et al,. Seroprevalence of anti-hepatitis a antibody among 1-15 year old children in Kashan-Iran. Hepat Mon 2013; 13 (5): e10553.
27. Taghavi SA, Hosseini Asl MK, Talebzadeh M, et al,. Seroprevalence study of hepatitis A virus in Fars Province, Southern Iran. Hepat Mon 2011; 11 (4): 285-288.
28. Abdo AA, Sanai FM, Al-Faleh FZ,. Epidemiology of viral hepatitis in Saudi Arabia: are we off the hook? Saudi J Gastroenterol 2012; 18 (6): 349-357.
29. Almuneef MA, Memish ZA, Balkhy HH, et al,. Epidemiologic shift in the prevalence of Hepatitis A virus in Saudi Arabia: a case for routine Hepatitis A vaccination. Vaccine 2006; 24 (27-28): 5599-5603.
30. Al Faleh F, Al Shehri S, Al Ansari S, et al,. Changing patterns of hepatitis A prevalence within the Saudi population over the last 18 years. World J Gastroenterol 2008; 14 (48): 7371-7375.
31. Jaber SM,. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia. Saudi Med J 2006; 27 (10): 1515-1522.
32. Almuneef MA, Memish ZA, Balkhy HH, et al,. Seroprevalence survey of varicella, measles, rubella, and hepatitis A and B viruses in a multinational healthcare workforce in Saudi Arabia. Infect Control Hosp Epidemiol 2006; 27 (11): 1178-1183.
33. El-Gilany AH, Hammad S, Refaat K, et al,. Seroprevalence of hepatitis A antibodies among children in a Saudi community. Asian Pac J Trop Med 2010; 3 (4): 278-282.
34. Memish ZA, Knawy BA, El-Saed A,. Incidence trends of viral hepatitis A, B, and C seropositivity over eight years of surveillance in Saudi Arabia. Int J Infect Dis 2010; 14 (2): e115-e120.
35. Bawazir AA, Hart CA, Sallam TA, et al,. Seroepidemiology of hepatitis A and hepatitis E viruses in Aden, Yemen. Trans R Soc Trop Med Hyg 2010; 104 (12): 801-805.
36. Salama II, Samy SM, Shaaban FA, et al,. Seroprevalence of hepatitis A among children of different socioeconomic status in Cairo. East Mediterr Health J 2007; 13 (6): 1256-1264.
37. Louati N, Feki L, Rekik H, et al,. Comparison of hepatitis A seroprevalence in blood donors in South Tunisia between 2000 and 2007. Arch Inst Pasteur Tunis 2009; 86 (1-4): 69-74.
38. Gharbi-Khelifi H, Abid NB, Beji A, et al,. Seroprevalence and molecular characterisation of human hepatitis A virus in serum samples of Tunisian patients with clinical symptoms of viral hepatitis. Indian J Virol 2012; 23 (1): 29-35.
39. Alkhalidi J, Alenezi B, Al-Mufti S, et al,. Seroepidemiology of hepatitis A virus in Kuwait. World J Gastroenterol 2009; 15 (1): 102-105.
40. Sharar ZA, Rajah J, Parsons H,. Childhood seroprevalence of hepatitis A in the United Arab Emirates. Trop Doct 2008; 38 (1): 65-66.
41. Smahi MC, Rahmoun L, Ghomari SM, et al,. Seroprevalence and risk factors of hepatitis A among children in Tlemcen (north-west Algeria). Arch Pediatr 2009; 16 (6): 844-846.
42. Ataallah M, Turky WA, Ahmed S, et al,. Analysis of acute viral hepatitis (A and E) in Iraq. Glob J Health Sci 2011; 3 (1): 70-76.
43. Bouskraoui M, Bourrous M, Amine M,. Prevalence of anti-hepatitis A virus antibodies in children in Marrakech. Arch Pediatr 2009; 16 (Suppl. 2): S132-S136.
44. Unicef. Progress on drinking water and sanitation 2012 [updated 2012]. Available at: http://www.unicef.org/media/files/JMPreport2012.pdf (accessed 5 April 2014).
45. Wintgens T, Melin T, Schäfer A, et al,. The role of membrane processes in municipal wastewater reclamation and reuse. Desalination 2005; 178: 1-11.
46. Sonune A, Ghate R,. Developments in wastewater treatment methods. Desalination 2004; 167: 55-63.
47. Kivaisi AK,. The potential for constructed wetlands for wastewater treatment and reuse in developing countries: a review. Ecol Eng 2001; 16 (4): 545-560.
48. Qadir M, Bahri A, Sato T, et al,. Wastewater production, treatment, and irrigation in Middle East and North Africa. Irrigation and Drainage Systems 2010; 24 (1-2): 37-51.
49. Council TAW,. The democratic and popular Republic of Algeria Ministry of Water Resources [updated 2011]. Available at: http://www.arabwatercouncil.org/ administrator/Modules/CMS/Algeria-Country-Report.pdf (accessed 5 April 2014).
50. Global Water Intelligence, Tunisia. Global water and wastewater quality regulations. 2012: 252-270. Available at: http://www.globalwaterintel.com/ client-media/uploaded/Global%20Regulation/Sample-Chapter.pdf (accessed 5 April 2014).
51. Global Water Intelligence. Israel fast-tracks wastewater treatment upgrades [updated 2013]. Available at: http://www.globalwaterintel.com/archive/ 11/2/general/israel-fast-tracks-wastewater-treatment-upgrades.html (accessed 15 November 2013).
52. Abufayed AA, Elkebir AA,. Water supply and sanitation in Libya: gap analysis, national needs assessment and UNDP interventions [updated 2010]. Available at: http://www.wgpas-undp.org/Reports/NNA-Libya.pdf (accessed 10 November 2013).
53. Gueye L, Bzioui M, Johnson O,. Water and sustainable development in the countries of Northern Africa: coping with challenges and scarcity in Assessing Sustainable Development in Africa 2005. Africa's Sustainable Development Bulletin: 24-28.
54. Naddafi K, Hassanvand M, Dehghanifard E, et al,. Performance evaluation of wastewater stabilization ponds in Arak-Iran. Iranian J Environ Health Sci Eng 2009; 6 (1): 41-46.
55. United Nations Environmental Programme Division of Technology IaE. Sourcebook of alternative technologies for freshwater augmentation in West Asia. Available at: http://www.unep.or.jp/ietc/publications/techpublications/techpub- 8f/c/Bahrain1.asp (accessed 19 November 2013).
56. Limassol SBo. Tetriary treatment plant. Available at: http://www.sbla.com.cy/site/en/sewage-plant/sewage-plant-operation.html (accessed 19 November 2013).
57. Lattemann S, Höpner T,. Environmental impact and impact assessment of seawater desalination. Desalination 2008; 220 (1): 1-15.
58. Younos T, Tulou KE,. Overview of desalination techniques. J Contemp Water Res Educ 2005; 132 (1): 3-10.
59. de Roda Husman AM, Bartram J,. Global supply of virus-safe drinking water. Perspect Med Virol 2007; 17: 127-162.
60. Ettouney HM, El-Dessouky HT, Faibish RS, et al,. Evaluating the economics of desalination. Chem Eng Prog 2002; 98 (12): 32-40.
61. Dawoud MA, Al Mulla M,. Environmental impacts of seawater desalination: Arabian Gulf case study. Int J Environ Sustain 2012; 1 (3): 22-37.
62. FAO Fact Sheet. Country fact sheet Somalia. Available at: http://www.fao.org/nr/water/aquastat/data/cf/readPdf.html?f=CF-SOM-en.pdf (accessed 15 November 2013).
63. FAO Fact Sheet. Country fact sheet Sudan. Available at: http://www.fao.org/nr/water/aquastat/data/cf/readPdf.html?f=CF-SDN-en.pdf (accessed 15 November 2013).
64. FAO Fact Sheet. Country fact sheet Mauritania. Available at: http://www.fao.org/nr/water/aquastat/data/cf/readPdf.html?f=CF-MRT-en.pdf (accessed 15 November 2013).
65. FAO Fact Sheet. Country fact sheet Djibouti. Available at: http://www.fao.org/nr/water/aquastat/data/cf/readPdf.html?f=CF-DJI-en.pdf (accessed 15 November 2013).
66. El-Sheikh RA, Jung H, Koegler T,. Diagnosis of limitations in operational capacity of sea water desalination plants in Gaza strip. LNCV International Forum 'Food Security under Water Scarcity in the Middle East: Problems and Solutions'. November 24-27, 2004; Como, Italy, 2005.
67. FAO Fact Sheet. Country fact sheet Morroco. Available at: http://www.fao.org/nr/water/aquastat/data/cf/readPdf.html?f=CF-MAR-en.pdf (accessed 20 November 2013).
68. FAO Fact Sheet. Country fact sheet Iraq. Available at: http://www.fao.org/nr/water/aquastat/data/cf/readPdf.html?f=CF-IRQ-en.pdf (accessed 20 November 2013).
69. FAO Fact Sheet. Country fact sheet Jordan. Available at: http://www.fao.org/nr/water/aquastat/countries-regions/jordan/index.stm (accessed 15 November 2013).
70. FAO Fact Sheet. Country fact sheet Yemen. Available at: http://www.fao.org/nr/water/aquastat/data/cf/readPdf.html?f=CF-YEM-en.pdf (accessed 15 November 2013).
71. FAO Fact Sheet. Country fact sheet Cyprus. Available at: http://www.fao.org/nr/water/aquastat/data/cf/readPdf.html?f=CF-CYP-en.pdf (accessed 15 November 2013).
72. The International Desalination & Water Reuse. Desalination booming in Tunisia [updated August 2010]. Available at: http://www.desalination.biz/news/ news-story.asp?id=5431&title=Desalination+booming+in+Tunisia (accessed 15 November 2013).
73. Drouiche N, Ghaffour N, Naceur MW, et al,. Reasons for the fast growing seawater desalination capacity in Algeria. Water Resour Manage 2011; 25 (11): 2743-2754.
74. FAO Fact Sheet. Country fact sheet Lebanon. Available at: http://www.fao.org/nr/water/aquastat/data/cf/readPdf.html?f=CF-LBN-en.pdf (accessed 20 November 2013).
75. Tenne A,. Sea water desalination in Israel: planning, coping with difficulties, and economic aspects of long-term risks [updated 2010]. Available at: http://www.water.gov.il/Hebrew/Planning-and-Development/Desalination/ Documents/Desalination-in-Israel.pdf (accessed 20 November 2013).
76. Global Water Intelligence. Desalination market in Egypt to reach $393.8 m by 2016 [updated 2010]. Available at: http://www.prlog.org/ 10985677-desalination-market-in-egypt-to-reach-3938m-by-2016-new-gwi-report. html (accessed 10 November 2013).
77. Global Water Intelligence. Desalination market in Turkey to reach $226.2 m by 2016 [updated 2010]. Available at: http://www.prlog.org/ 10984924-desalination-market-in-turkey-to-reach-2262m-by-2016-new-gwi-report. html (accessed 10 November 2013).
78. Organization WH. Hepatitis A [updated 2014]. Available at: http://www.who.int/csr/disease/hepatitis/whocdscsredc2007/en/index4.html (accessed 5 May 2014).
79. Wasley A, Fiore A, Bell BP,. Hepatitis A in the era of vaccination. Epidemiol Rev 2006; 28: 101-111.
80. Demicheli V, Carniglia E, Fucci S,. The use of hepatitis a vaccination in Italy: an economic evaluation. Vaccine 2003; 21 (19-20): 2250-2257.
81. Dominguez A, Salleras L, Carmona G, et al,. Effectiveness of a mass hepatitis A vaccination program in preadolescents. Vaccine 2003; 21 (7-8): 698-701.
82. Vacchino MN,. Incidence of hepatitis A in Argentina after vaccination. J Viral Hepat 2008; 15 (Suppl. 2): 47-50.
83. WHO position paper on hepatitis A vaccines: June 2012-recommendations. Vaccine 2013; 31 (2): 285-286.
84. Unicef, World Health Organization. Immunization summary [updated 2013]. Available at: http://www.unicef.org/videoaudio/PDFs/EN-ImmSumm-2013.pdf (accessed 5 May 2014).
85. Bovier PA, Bock J, Ebengo TF, et al,. Predicted 30-year protection after vaccination with an aluminum-free virosomal hepatitis A vaccine. J Med Virol 2010; 82 (10): 1629-1634.
86. UNHCR. Syrian regional refugee response inter-agency information sharing portal [updated 2014]. Available at: http://data.unhcr.org/syrianrefugees/ regional.php (accessed 5 May 2014).
87. Lebanese Ministry of Public Health, World Health Organization. Lebanese weekly epi-monitor [updated Februaury 2014]. Available at: http://www.moph.gov. lb/Prevention/Surveillance/documents/epimonitor-20140215.pdf (accessed 5 May 2014).
88. Lavanchy D,. Viral hepatitis: global goals for vaccination. J Clin Virol 2012; 55 (4): 296-302.
89. Letaief A, Kaabia N, Gaha R, et al,. Age-specific seroprevalence of hepatitis a among school children in central Tunisia. Am J Trop Med Hyg 2005; 73 (1): 40-43.
90. Rezig D, Ouneissa R, Mhiri L, et al,. [Seroprevalences of hepatitis A and E infections in Tunisia]. Pathol Biol (Paris) 2008; 56 (3): 148-153.